HBIMEDICAL ApS: Financial statements 2022
CVR: 36426063
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HBIMEDICAL ApS (CVR 36426063) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 38,949 and a net result of DKK 36,261 compared with DKK 118,844 the year before. That is a decrease of 68.9% compared with the year before. Equity in the 2022 report amounted to DKK 205,044. The solvency ratio was 43.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 38,949
- Profit/Loss
- DKK 36,261
- Equity
- DKK 205,044
- Total Assets
- DKK 475,341
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 39 t. | 36 t. | 205 t. | 1 |
| 2021 | - | 125 t. | 119 t. | 219 t. | 1 |
| 2020 | - | 83 t. | 78 t. | 100 t. | 1 |
| 2019 | - | 154 t. | 118 t. | 22 t. | 1 |
| 2018 | - | -128 t. | -150 t. | -96 t. | 1 |
Official annual report
Keep an eye on HBIMEDICAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HBIMEDICAL ApS has published its annual report for 2021. Gross profit came to DKK 125,287, and the net result was DKK 118,844.
About HBIMEDICAL ApS
HBIMEDICAL ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Hanne Busch Ibsen. The company is owned by Hanne Busch Ibsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -34,441 and a net result of DKK -34,479 compared with DKK 42,098 the year before. Equity in the 2025 report amounted to DKK 145,118.